MedPath

RIVASTIGMINA TEVA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

RIVASTIGMINA TEVA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Commercialized
Register Number

79977

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 9, 2015

Dosage Form

PARCHE TRANSDÉRMICO

Route: VÍA TRANSDÉRMICA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number79977
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RIVASTIGMINAActive
Quantity: 27 mg
Name: RIVASTIGMINA

ATC CLASSIFICATION (3)

N06D
N06DA
N06DA03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.